A detailed history of Black Rock Inc. transactions in Repligen Corp stock. As of the latest transaction made, Black Rock Inc. holds 7,773,131 shares of RGEN stock, worth $1.16 Billion. This represents 0.03% of its overall portfolio holdings.

Number of Shares
7,773,131
Previous 7,859,645 1.1%
Holding current value
$1.16 Billion
Previous $1.41 Billion 1.17%
% of portfolio
0.03%
Previous 0.04%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$170.78 - $208.42 $14.8 Million - $18 Million
-86,514 Reduced 1.1%
7,773,131 $1.43 Billion
Q4 2023

Feb 13, 2024

SELL
$114.17 - $185.35 $3.03 Million - $4.91 Million
-26,511 Reduced 0.34%
7,859,645 $1.41 Billion
Q3 2023

Nov 13, 2023

BUY
$138.78 - $176.51 $13.2 Million - $16.8 Million
95,079 Added 1.22%
7,886,156 $1.25 Billion
Q2 2023

Aug 11, 2023

BUY
$138.42 - $180.31 $72.3 Million - $94.1 Million
522,128 Added 7.18%
7,791,077 $1.1 Billion
Q1 2023

May 12, 2023

BUY
$154.26 - $198.1 $177 Million - $227 Million
1,145,110 Added 18.7%
7,268,949 $1.22 Billion
Q4 2022

Feb 13, 2023

BUY
$162.42 - $220.56 $33.2 Million - $45.1 Million
204,650 Added 3.46%
6,123,839 $1.04 Billion
Q3 2022

Nov 14, 2022

BUY
$160.42 - $256.21 $90.6 Million - $145 Million
564,862 Added 10.55%
5,919,189 $1.11 Billion
Q2 2022

Aug 12, 2022

SELL
$140.68 - $188.02 $1.55 Million - $2.07 Million
-11,030 Reduced 0.21%
5,354,327 $870 Million
Q1 2022

May 12, 2022

BUY
$161.19 - $257.96 $28.4 Million - $45.4 Million
176,168 Added 3.39%
5,365,357 $1.01 Billion
Q4 2021

Feb 10, 2022

SELL
$247.59 - $304.47 $8.49 Million - $10.4 Million
-34,281 Reduced 0.66%
5,189,189 $1.37 Billion
Q3 2021

Nov 09, 2021

SELL
$194.77 - $324.21 $17.3 Million - $28.8 Million
-88,794 Reduced 1.67%
5,223,470 $1.51 Billion
Q2 2021

Aug 11, 2021

BUY
$165.87 - $220.95 $881 Million - $1.17 Billion
5,312,264 New
5,312,264 $1.06 Billion

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.27B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.